COVID-19 Booster Readiness Survey

Not Applicable

Completed

• Conditions: Vaccination Refusal
• Interventions: Behavioral: Other-protection message; Behavioral: Salience of Omicron variant; Behavioral: Self-protection message

• Registration Number: NCT05529030
• Lead Sponsor: Geisinger Clinic

Brief Summary

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Detailed Description

The Food and Drug Administration has authorized two bivalent COVID-19 boosters with the expectation that the Centers for Disease Control will soon recommend them. The researchers plan to survey the HCWs at a large, rural health system on their attitudes on the bivalent booster.

This survey will gather data on HCWs' interest in a bivalent booster, reasons for hesitancy, risk perception about COVID-19 infection and its complications, and prior COVID-19 infection and vaccination.

Respondents will also be randomly assigned to see different versions of the question asking if they are interested in a bivalent booster with different framing approaches, such as protection of the self or protection of patients (for patient-facing employees). Information on prior vaccination and perceptions of risk will also be gathered and used as covariates in the analysis.

Study Timeline

• Status Verified: 2022-09
• Study Start: 2022-09-01
• Study First Submitted: 2022-09-01
• Study First Submitted QC: 2022-09-01
• Study First Posted: 2022-09-06
• Primary Completion: 2022-09-15
• Study Completion: 2022-09-15
• Last Update Submitted: 2022-09-28
• Last Update Posted: 2022-09-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12036

Inclusion Criteria

• Employee at the health system

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Question with patient protection message	Other-protection message	Question indicates that the bivalent booster can protect patients (only presented to patient-facing employees)
Question with salient Omicron message	Self-protection message	Question indicates that the bivalent booster can protect the respondent from the Omicron variant
Question with salient Omicron message	Salience of Omicron variant	Question indicates that the bivalent booster can protect the respondent from the Omicron variant
Question with salient Omicron and patient protection message	Salience of Omicron variant	Question indicates that the bivalent booster can protect patients from the Omicron variant (only presented to patient-facing employees)

Primary Outcome Measures

Name	Time	Method
Count of employees who indicate interest in the booster	14 days	Number of employees who indicate that they plan to get the booster when it is available

Trial Locations

Locations (1)

Geisinger Clinic; 🇺🇸 Danville, Pennsylvania, United States